bioRxivCell BiologyPreprint
Condensate-Driven Triglyceride Depletion Links alpha-Synuclein to Mitochondrial Dysfunction
Tao ZhangiD, María Eugenia GoyaiD, Alejandro Herrón-BedoyaiD, Jorien C. van der Weerd, Dikaia TsagkariiD, Suzanne CouzijniD, Lale GüngördüiD, Renée I. SeinstraiD, Margaretha Rebecca Heiner-FokkemaiD, Ming ChangiD, Nektarios TavernarakisiD, Folkert KuipersiD, Ellen A. A. NolleniD
Abstract
Inclusions of -Synuclein (Syn) characterize multiple age-related neurodegenerative diseases, including Parkinsons disease (PD) and Multiple System Atrophy (MSA). While interactions between Syn and lipids are known to contribute to Syn pathobiology, the precise cellular mechanisms that link lipids to Syn toxicity have yet to be elucidated. Through lipidomic profiling of Caenorhabditis elegans, we found that Syn progressively alters lipid metabolism in aging worms. Syn strongly reduces overall content of triacylglycerols (TAG) and disrupts the structure of lipid droplets (LD). These pathological changes depend on Syns properties to condensate and form inclusions. Apart from lowering TAG levels, Syn also increases the proportion of long-chain unsaturated fatty acids (LCUFAs). Consequently, genetic inhibition of LCUFA biosynthesis alleviates Syn-induced loss of C. elegans motility. Strikingly, bypassing lipid metabolic defects by supplementing Medium Chain Fatty Acids (MCFAs) restores the Syn-impaired mitochondrial response and rescues motility. These results link Syn condensation to impaired TAG metabolism, which reduces mitochondrial function and enhances overall toxicity. Together with the finding that plasma TAGs are lowered in Parkinson patient cohorts, these results suggest that restoring TAG metabolism could alleviate Syn-induced toxicity in Parkinsons and other age-related synucleinopathies.
- organism: C. elegans
- assay: metabolomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The Role of Alpha Synuclein in Synucleinopathy: Impact on Lipid Regulation at Mitochondria ER Membranes
Peter A. Barbuti, Cristina Guardia‐Laguarta, … Serge Przedborski·npj Parkinson s DiseasePeer-reviewed·Apr 30, 2025
- Lipid droplets promote the aberrant liquid-liquid phase separation of alpha-synuclein leading to impaired energy homeostasis
Jose Cevallos, Elena Eubanks, … Eleanna Kara·bioRxiv·Nov 20, 2025
- A non-canonical lipid droplet metabolism regulates the conversion of alpha-Synuclein to proteolytic resistant forms in neurons of a Drosophila model of Parkinson disease
V. Girard, F. Jollivet, … B. Mollereau·bioRxiv·Sep 16, 2020
- Pathological levels of α-synuclein increase basal mitophagy in Parkinson's dopamine neurons
E. D. Mock, B. Vallin, … R. Wade-Martins·bioRxiv·Nov 2, 2026
- α-Synuclein Activates the PI3K/AKT Pathway to Drive Lipid Droplets Accumulation: Implications for Parkinson's Disease
Suaad Abd Elhadi, Jenna Congdon-Loeffler, … Ronit Sharon·bioRxiv·Mar 27, 2025
- Alpha-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinsons disease
Fanni F. Geibl, Martin T. Henrich, … Dalton James Surmeier·Molecular NeurodegenerationPeer-reviewed·Oct 8, 2024